ElleVet Sciences, a prominent company specializing in CBD+CBDA solutions for pets, has officially received US Patent No. 11,712,456, which encompasses the application of hemp extracts for treating pain and various ailments in animals. Amanda Howland, Co-Founder and Chief Commercial Officer of ElleVet Sciences, remarked, “This achievement is a significant triumph for ElleVet and exemplifies our commitment to scientific advancement.” She emphasized that their exclusive formula has been instrumental in their unparalleled success, reiterating that not all hemp products are equal and that ElleVet stands out as the premier choice for pets.
With its reputation as a trailblazer in hemp products for pets, ElleVet Sciences conducted the pioneering first-ever clinical trial on dogs with osteoarthritis in collaboration with Cornell University College of Veterinary Medicine in 2017. This trial yielded impressive results, with 75% of the dogs experiencing substantial improvements in comfort and mobility.
Christian Kjaer, CEO and Co-Founder of ElleVet Sciences, highlighted their dedication to groundbreaking science, and this patent marks the beginning of a series of anticipated patents to be granted in the coming years. The patents will safeguard their ongoing investments in research and development, aiming to enhance the lives of pets through scientific innovation.
ElleVet’s patented hemp extract has consistently demonstrated its superiority compared to other products on the market, making it the preferred choice among veterinarians. The company’s advisory board includes esteemed veterinarians, along with Chief Veterinary Medical Officer Dr. Joseph Wakshlag, who holds double board certification.
The proprietary CBD+CBDA blend, protected by the patent, has shown success in clinical trials related to conditions like atopic dermatitis and epilepsy. This indicates that the blend, now patented for its effectiveness in addressing pain in dogs, holds promise for broader applications.
Christian Kjaer expressed pride in ElleVet’s leading market position as a science-driven company dedicated to exploring the potential of hemp, particularly CBD+CBDA. He noted that there is still much to uncover in this field and emphasized their research into different acidic forms of hemp molecules, a pursuit they eagerly anticipate sharing with the scientific community.
About ElleVet Sciences:
ElleVet Sciences is a reputable pet CBD+CBDA company headquartered in Portland, Maine, USA. The company stands as a trailblazer in conducting clinical trials with proven outcomes, utilizing their unique cannabinoid and terpene oil blend. Founded in 2017 by Christian Kjaer and Amanda Howland, ElleVet Sciences comprises a team with a blend of scientific and veterinary expertise, united by a passion for animals, research, and innovation.